NCT07069699 2026-03-18Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC GeneNational Cancer Institute (NCI)Phase 1/2 Recruiting50 enrolled